none2Around 2 billion people consume alcoholic beverages worldwide, and almost 10% of the world’s population is affected by Alcohol- Use Disorders (AUDs). Alcohol consumption is responsible for approximately 3.8% of all deaths and accounts for 5.5% of the global burden of disease. So far, only three drugs [Naltrexone (NTX), Acamprosate (ACM), and Disulfiram (DF)] have been approved by the Food and Drug Administration for the treatment of alcohol dependence; however, emerging data from clinical trials suggest that these medications are relatively ineffective in maintaining the abstinence from alcohol.mixedCaputo F; Bernardi M.Caputo F; Bernardi M
BACKGROUND: European Medicines Agency guidelines recognize two different treatment goals for alcohol...
Naltrexone can help prevent relapse in recently detoxified patients with alcohol use disorder. The e...
Medical treatment of alcohol dependence: a systematic review. Miller P.M., Book S.W., Stewart S.H.I...
Alcohol use disorders (AUD) cause significant morbidity and mortality worldwide, but pharmacological...
Alcohol use disorder is one of the most significant and common psychiatric diagnoses in the United S...
Alcoholism, a major public health problem throughout the world, causes enormous damage to health and...
Very few medications (i.e., disulfiram, naltrexone and acamprosate) are approved for the treatment o...
Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with only thre...
Introduction: Alcohol Use Disorders (AUD) is a leading cause of mortality and morbidity worldwide. A...
Background: Pharmacotherapy for Alcohol Dependence (AD) is underutilized. Barriers preventing use of...
Compounds known to be successful in the treatment of alcohol use disorder include the aversive agent...
International audienceBackground and aims - Pharmacologically controlled drinking in the treatment o...
Alcohol dependence is a chronic disorder that results from a variety of genetic, psychosocial, and e...
none7Alcoho use disorders afflict almost 10% of the worldwide population, cause approximately 3.8% o...
Almost 10% of the world's population is affected by alcohol use disorders, and the treatment of alco...
BACKGROUND: European Medicines Agency guidelines recognize two different treatment goals for alcohol...
Naltrexone can help prevent relapse in recently detoxified patients with alcohol use disorder. The e...
Medical treatment of alcohol dependence: a systematic review. Miller P.M., Book S.W., Stewart S.H.I...
Alcohol use disorders (AUD) cause significant morbidity and mortality worldwide, but pharmacological...
Alcohol use disorder is one of the most significant and common psychiatric diagnoses in the United S...
Alcoholism, a major public health problem throughout the world, causes enormous damage to health and...
Very few medications (i.e., disulfiram, naltrexone and acamprosate) are approved for the treatment o...
Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with only thre...
Introduction: Alcohol Use Disorders (AUD) is a leading cause of mortality and morbidity worldwide. A...
Background: Pharmacotherapy for Alcohol Dependence (AD) is underutilized. Barriers preventing use of...
Compounds known to be successful in the treatment of alcohol use disorder include the aversive agent...
International audienceBackground and aims - Pharmacologically controlled drinking in the treatment o...
Alcohol dependence is a chronic disorder that results from a variety of genetic, psychosocial, and e...
none7Alcoho use disorders afflict almost 10% of the worldwide population, cause approximately 3.8% o...
Almost 10% of the world's population is affected by alcohol use disorders, and the treatment of alco...
BACKGROUND: European Medicines Agency guidelines recognize two different treatment goals for alcohol...
Naltrexone can help prevent relapse in recently detoxified patients with alcohol use disorder. The e...
Medical treatment of alcohol dependence: a systematic review. Miller P.M., Book S.W., Stewart S.H.I...